Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
Research Provides Further Evidence for the Mechanism of Action Underlying Hythiam’s PROMETA® Treatment Program
Greg McLane Joins Hythiam as Senior Vice President, Sales and Marketing
CORRECTING and REPLACING Hythiam Announces Third Quarter Results
Hythiam Announces Third Quarter Results
Hythiam to Present at Rodman & Renshaw's 10th Annual Healthcare Conference
Hythiam to Announce Third Quarter Results on Thursday, November 6th
Hythiam to Present at Merriman Curhan Ford 2008 Investor Conference
Hythiam Announces Second Quarter Results
Hythiam to Announce Second Quarter Results on Monday, August 11th
Hythiam Announces Presentation at BMO Capital Markets 8th Annual Focus on Healthcare Conference
Intent-to-Treat Analysis of Double-Blind Methamphetamine Study Confirms Hythiam's PROMETA Treatment Program Showed Statistically Significant Reduction in Cravings Compared to Placebo
Hythiam Announces Presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference in Monaco
Hythiam Announces First Quarter Results
Hythiam Announces Commercial Reimbursement with National Third-Party Payor
Hythiam to Announce First Quarter Results on Monday, May 12Th
Advertisements
Home
|
Login
|
Research
|
Earnings
|
Scans
|
Chat Rooms
|
Charts
|
Submit Article
|
Join Blog Network
|
Contributors
|
copryright 2008 all rights reserved
